Advance online publication
Papers are listed below grouped by their online publication date.
October 27 2009 |
October 20 2009 |
October 13 2009 |
October 6 2009 |
September 29 2009
November 3 2009
Minireviews
Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
A M Traish and A Morgentaler
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605376
Family history and the risk of gastric cancer
M Yaghoobi, R Bijarchi and S A Narod
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605380
Short Communication
Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
M Mego, U De Giorgi, K Broglio, S Dawood, V Valero, E Andreopoulou, B Handy, J M Reuben and M Cristofanilli
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605413
Full Papers
Geographical and temporal distribution of cancer survival in teenagers and young adults in England
M Geraci, T O B Eden, R D Alston, A Moran, R S Arora and J M Birch
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605410
Increase in tumour permeability following TGF-
type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI
T Minowa, K Kawano, H Kuribayashi, K Shiraishi, T Sugino, Y Hattori, M Yokoyama and Y Maitani
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605367
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
A-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, S Romeo, J Oosting, R M Egeler, H Gelderblom, A H M Taminiau and P C W Hogendoorn
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605405
Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease
S Darby, T Murphy, H Thomas, C N Robson, H Y Leung, M E Mathers and V J Gnanapragasam
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605379
Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
M Hirotsu, T Setoguchi, Y Matsunoshita, H Sasaki, H Nagao, H Gao, K Sugimura and S Komiya
Br J Cancer advance online publication, November 3, 2009; doi:10.1038/sj.bjc.6605407
October 27 2009
Full Papers
Activation and clinical significance of the unfolded protein response in breast cancer
P Scriven, S Coulson, R Haines, S Balasubramanian, S Cross and L Wyld
Br J Cancer advance online publication, October 27, 2009; doi:10.1038/sj.bjc.6605365
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
G E Konecny, R Glas, J Dering, K Manivong, J Qi, R S Finn, G R Yang, K-L Hong, C Ginther, B Winterhoff, G Gao, J Brugge and D J Slamon
Br J Cancer advance online publication, October 27, 2009; doi:10.1038/sj.bjc.6605381
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
N Orsini, R Bellocco, M Bottai, M Pagano, S-O Andersson, J-E Johansson, E Giovannucci and A Wolk
Br J Cancer advance online publication, October 27, 2009; doi:10.1038/sj.bjc.6605404
Assessment of breast cancer opportunistic screening by clinical–pathological indicators: a population-based study
A Bordoni, N M Probst-Hensch, L Mazzucchelli and A Spitale
Br J Cancer advance online publication, October 27, 2009; doi:10.1038/sj.bjc.6605378
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
R E Board, G Ellison, M C M Orr, K R Kemsley, G McWalter, L Y Blockley, S P Dearden, C Morris, M Ranson, M V Cantarini, C Dive and A Hughes
Br J Cancer advance online publication, October 27, 2009; doi:10.1038/sj.bjc.6605371
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
S Ganai, R B Arenas and N S Forbes
Br J Cancer advance online publication, October 27, 2009; doi:10.1038/sj.bjc.6605403
October 20 2009
Full Papers
Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate
J E Elkahwaji, R J Hauke and C M Brawner
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605370
Clinical importance of B7-H3 expression in human pancreatic cancer
I Yamato, M Sho, T Nomi, T Akahori, K Shimada, K Hotta, H Kanehiro, N Konishi, H Yagita and Y Nakajima
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605375
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
T Terakawa, H Miyake, J Furukawa, S L Ettinger, M E Gleave and M Fujisawa
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605358
Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
A M Jubb, H Turley, H C Moeller, G Steers, C Han, J-L Li, R Leek, E Y Tan, B Singh, N J Mortensen, I Noguera-Troise, F Pezzella, K C Gatter, G Thurston, S B Fox and A L Harris
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605368
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
K Lundgren, B Nordenskjöld and G Landberg
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605369
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
M Toi, H Iwata, Y Fujiwara, Y Ito, S Nakamura, Y Tokuda, T Taguchi, Y Rai, K Aogi, T Arai, J Watanabe, T Wakamatsu, K Katsura, C E Ellis, R C Gagnon, K E Allen, Y Sasaki and S Takashima
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605343
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors FREE
R Kumar, M-C Crouthamel, D H Rominger, R R Gontarek, P J Tummino, R A Levin and A G King
Br J Cancer advance online publication, October 20, 2009; doi:10.1038/sj.bjc.6605366
Abstract | Full Text | PDF | Supplementary information
October 13 2009
Full Papers
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
C Yoo, J Y Hwang, J-E Kim, T W Kim, J S Lee, D H Park, S S Lee, D W Seo, S K Lee, M-H Kim, D J Han, S C Kim and J-L Lee
Br J Cancer advance online publication, October 13, 2009; doi:10.1038/sj.bjc.6605374
Brain metastases admissions in Sweden between 1987 and 2006
K E Smedby, L Brandt, M L Bäcklund and P Blomqvist
Br J Cancer advance online publication, October 13, 2009; doi:10.1038/sj.bjc.6605373
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease
M W M D Lutgens, B Oldenburg, P D Siersema, A A van Bodegraven, G Dijkstra, D W Hommes, D J de Jong, P C F Stokkers, C J van der Woude and F P Vleggaar
Br J Cancer advance online publication, October 13, 2009; doi:10.1038/sj.bjc.6605359
Familial association of pancreatic cancer with other malignancies in Swedish families
E Hiripi, J Lorenzo Bermejo, X Li, J Sundquist and K Hemminki
Br J Cancer advance online publication, October 13, 2009; doi:10.1038/sj.bjc.6605363
Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells
D Hong, W Lu, F Ye, Y Hu and X Xie
Br J Cancer advance online publication, October 13, 2009; doi:10.1038/sj.bjc.6605344
October 6 2009
Minireview
The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
J Griggs and K Zinkewich-Peotti
Br J Cancer advance online publication, October 6, 2009; doi:10.1038/sj.bjc.6605349
Full Paper
Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas
J M Pita, A Banito, B M Cavaco and V Leite
Br J Cancer advance online publication, October 6, 2009; doi:10.1038/sj.bjc.6605340
September 29 2009
Minireview
Preclinical mouse models for BRCA1-associated breast cancer
R M Drost and J Jonkers
Br J Cancer advance online publication, September 29, 2009; doi:10.1038/sj.bjc.6605350
Full Paper
Epoetin-
treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events
M Aapro, B Osterwalder, A Scherhag and H U Burger
Br J Cancer advance online publication, September 29, 2009; doi:10.1038/sj.bjc.6605255
Until print versions of AOP papers are published, they should be cited in the style "Author(s) British Journal of Cancer advance online publication, day month year doi:10.1038/sj.bjc.XXXXXXX". Once the print version (identical to the AOP) is published, it should be cited as follows: "Author(s) British Journal of Cancer volume, page year; advance online publication, doi:10.1038/sj.bjc.XXXXXXX".
For more information visit the BJC about aop information page.
